A detailed history of Brevan Howard Capital Management LP transactions in Zoetis Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 8,407 shares of ZTS stock, worth $1.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,407
Previous 5,887 42.81%
Holding current value
$1.64 Million
Previous $996,000 46.29%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$145.54 - $178.83 $366,760 - $450,651
2,520 Added 42.81%
8,407 $1.46 Million
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $119,448 - $144,156
-721 Reduced 10.91%
5,887 $996,000
Q4 2023

Feb 14, 2024

BUY
$151.44 - $200.09 $72,994 - $96,443
482 Added 7.87%
6,608 $1.3 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $891,210 - $1.07 Million
6,126 New
6,126 $1.02 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $91.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.